国产精品一区二区av麻豆,国产成人综合色视频精品,亚洲伊人成综合网2222,国产凸凹视频一区二区

CD73分子(CD73)活性蛋白

Active Cluster Of Differentiation 73 (CD73)

NT5E; NT5-E; E5NT; E5-NT; NTE; EN; ENT; 5'-Nucleotidase, Ecto

  • CD73分子(CD73)活性蛋白產品包裝(模擬)
  • CD73分子(CD73)活性蛋白產品包裝(模擬)
  • CD73分子(CD73)活性蛋白Gene sequencing
  • APB250Hu01.jpgSDS-PAGE圖
  • CD73分子(CD73)活性蛋白Figure. Western Blot; Sample: Recombinant NT5E, Human.
  • Certificate通過ISO 9001、ISO 13485質量體系認證

活性實驗

5'-Nucleotidase, Ecto (NT5E), also known as ecto-5'-nucleotidase or CD73, is an enzyme catalyzing thehydrolysis of nucleoside-5’-monophosphates to nucleosides and inorganic phosphate. The enzyme is a dimer composed of 2 identical 70kD subunits bound by a glycosyl phosphatidyl inositol linkage to the external face of the plasma membrane. NT5E is a marker of lymphocyte differentiation that has functions independent of its catalytic activity, such as T-cell activation and cell-cell adhesion. Other forms of 5-prime nucleotidase exist in the cytoplasm and lysosomes and can be distinguished from NT5E by their substrate affinities, requirement for divalent magnesium ion, activation by ATP, and inhibition by inorganic phosphate. The enzyme is widely distributed in human and animal tissues. Besides, AF4/FMR2 Family, Member 1 (AFF1) has been identified as an interactor of NT5E thus a binding ELISA assay was conducted to detect the interaction of recombinant human NT5E and recombinant human AFF1. Briefly, NT5E were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100uL were then transferred to AFF1-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-NT5E pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50μL stop solution to the wells and read at 450nm immediately. The binding activity of of NT5E and AFF1 was shown in Figure 1, and this effect was in a dose dependent manner.

用法

Reconstitute in 20mM Tris, 150mM NaCl (pH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

儲存

避免反復凍融。2-8°C不超過一個月,-80°C不超過12個月。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。

相關產品

編號適用物種:Homo sapiens (Human,人)應用(僅供研究使用,不用于臨床診斷!)
APB250Hu01CD73分子(CD73)活性蛋白Cell?culture;?Activity?Assays.
RPB250Hu01CD73分子(CD73)重組蛋白Positive Control; Immunogen; SDS-PAGE; WB.
PAB250Hu01CD73分子(CD73)多克隆抗體WB; IHC
FAB250Hu01抗CD73分子(CD73)多克隆抗體Flow cytometry.
LAB250Hu81CD73分子(CD73)多克隆抗體(異硫氰酸熒光素標記)WB; IHC; ICC; IF.
LAB250Hu71CD73分子(CD73)多克隆抗體(生物素標記)WB; IHC; ICC.
FAB250Hu41抗CD73分子(CD73)多克隆抗體(藻紅素標記)Flow cytometry.
FAB250Hu51抗CD73分子(CD73)多克隆抗體(別藻藍蛋白標記)Flow cytometry.
FAB250Hu81抗CD73分子(CD73)多克隆抗體(異硫氰酸熒光素標記)Flow cytometry.
RAB250Hu21CD73分子(CD73)重組抗體WB; IF; ICC; IHC; IP; FCM.
MAB250Hu21CD73分子(CD73)單克隆抗體WB; IHC
MAB250Hu24CD73分子(CD73)單克隆抗體WB; IHC; ICC; IP.
MAB250Hu25CD73分子(CD73)單克隆抗體WB; IHC; ICC; IP.
MAB250Hu22CD73分子(CD73)單克隆抗體WB; IHC; ICC; IP.
MAB250Hu27CD73分子(CD73)單克隆抗體WB; IHC; ICC; IP.
MAB250Hu29CD73分子(CD73)單克隆抗體WB; ICC/IF
MAB250Hu23CD73分子(CD73)單克隆抗體IHC; ICC/IF
SEB250HuCD73分子(CD73)檢測試劑盒(酶聯免疫吸附試驗法)Enzyme-linked immunosorbent assay for Antigen Detection.
LMB250HuCD73分子(CD73)等多因子檢測試劑盒(流式熒光發(fā)光法)FLIA Kit for Antigen Detection.
KSB250Hu01CD73分子(CD73)檢測試劑盒DIY材料(酶聯免疫吸附試驗法)自己動手制作ELISA試劑盒的主要材料

參考文獻

雜志參考文獻
Journal of AutoimmunityThe expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation[Pubmed:25640206]
TalantaSimultaneous accurate quantification of HO-1, CD39, and CD73 in human calcified aortic valves using multiple enzyme digestion–filter aided sample pretreatment?…[10.1016:j.talanta.2018.01.044]
Cancer?BiomarkersExpression and clinical significance of serum NT5E protein in patients with colorectal cancer[Pubmed: 30932882]